These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 23353056)

  • 1. Advances for studying clonal evolution in cancer.
    Ding L; Raphael BJ; Chen F; Wendl MC
    Cancer Lett; 2013 Nov; 340(2):212-9. PubMed ID: 23353056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
    Patel LR; Nykter M; Chen K; Zhang W
    Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic sequencing in cancer.
    Tuna M; Amos CI
    Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the cancer methylome through targeted bisulfite sequencing.
    Lee EJ; Luo J; Wilson JM; Shi H
    Cancer Lett; 2013 Nov; 340(2):171-8. PubMed ID: 23200671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.
    Roberts NJ; Klein AP
    Cancer Lett; 2013 Nov; 340(2):227-33. PubMed ID: 23196058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion genes and their discovery using high throughput sequencing.
    Annala MJ; Parker BC; Zhang W; Nykter M
    Cancer Lett; 2013 Nov; 340(2):192-200. PubMed ID: 23376639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying molecular drivers of gastric cancer through next-generation sequencing.
    Liang H; Kim YH
    Cancer Lett; 2013 Nov; 340(2):241-6. PubMed ID: 23178814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
    Chan FC; Lim E; Kridel R; Steidl C
    J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
    Horswell S; Matthews N; Swanton C
    Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing of cancer genomes: lessons learned.
    Corrigan AE; Taylor R; Rallis KS
    Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
    [No Abstract]   [Full Text] [Related]  

  • 14. Next generation sequencing applications in cancer research.
    Zhang W; Nykter M; Chen K
    Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq.
    Feng H; Qin Z; Zhang X
    Cancer Lett; 2013 Nov; 340(2):179-91. PubMed ID: 23196057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular origins of cancer and future cancer therapy].
    Xie L; Hu WJ; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):81-84. PubMed ID: 29502365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal evolution models of tumor heterogeneity.
    Shlush LI; Hershkovitz D
    Am Soc Clin Oncol Educ Book; 2015; ():e662-5. PubMed ID: 25993239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches.
    Balzerano A; Paccosi E; Proietti-De-Santis L
    Cytogenet Genome Res; 2021; 161(6-7):362-371. PubMed ID: 34461614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.